Kelly Sparks

Kelly Sparks is a highly accomplished marketing professional with an impressive background in the healthcare industry. She received her MBA in Health Enterprise Management and Marketing from Northwestern University's Kellogg School of Management, where she developed her skills in market analytics and strategy. Prior to this, she received her Bachelor of Science in Commerce with distinction from the McIntire School of Commerce at the University of Virginia, where she focused on marketing, information technology, and international business and economics.

Sparks has gained a wealth of experience through her various roles, including her current position as Principal of Market Analytics & Strategy for Neurological Rare Diseases at Genentech. She has held various management positions at the company, including Associate Director of Market Analysis & Strategy for the Xolair product, Group Manager of OCREVUS Market Planning, and Senior Manager of IMPACT BD/IDCP Market Planning. Before joining Genentech, she worked as a Manager and Consultant for the Frankel Group, a Huron Life Sciences Solution at Huron Consulting Group. She also served as an Analyst at Dean & Company and as a Summer Fellow at Northwest Community Hospital.

Sparks' expertise lies in market analytics, strategy development, and planning. She possesses strong leadership and problem-solving skills and has a keen eye for analyzing market trends and formulating strategic plans. Her experience in the healthcare industry has allowed her to develop a deep understanding of the commercialization process, including product launch planning, marketing strategy, and business development.